|Bid||0.3300 x 0|
|Ask||0.3400 x 0|
|Day's range||0.3300 - 0.3390|
|52-week range||0.2750 - 3.5000|
|Beta (5Y monthly)||1.52|
|PE ratio (TTM)||N/A|
|Earnings date||05 Jun 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||16.10|
The company said initial investigations found no indications of any external transfer of sensitive or financial data and that costs to restore the systems were not expected to be material to its short-term cash flow. The company took some systems offline early last week after they were breached and appointed external investigators to look into the incident. London-listed Tissue Regenix said the incident is expected to hit order processing for a "very short-term" and that delayed orders would be shipped over the coming weeks.
The company said it had taken the affected systems offline, appointed external specialists to investigate the incident and was in talks with relevant legal authorities, but did not provide details on when the incident occurred or came to light. Tissue Regenix, which was formed in 2006 when it was spun-out from the University of Leeds, develops a special kind of tissue that is not rejected by a patient's body and can be used to repair diseased or worn out body parts. Tissue Regenix set up its U.S. unit in late 2012.
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...